Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA.
Department of Molecular Drug Evaluation, National Organization of Drug Control and Research, Giza, Egypt.
Dig Dis Sci. 2020 Mar;65(3):906-910. doi: 10.1007/s10620-020-06117-5.
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease characterized with the spectrum of hepatic steatosis, inflammation, and fibrosis. The etiology of NAFLD remains incompletely understood. Numerous studies have implied that the gut microbiota (GM) is involved in the development of NAFLD, as it particularly mediating the interaction between nutrient intake and the gut-liver function. Meanwhile, the omega-3 and omega-6 polyunsaturated fatty acids (n-3/n-6 PUFA) as essential fatty acids have been linked to NAFLD. Increasing studies in the past decades have indicated that there is a reciprocal interaction between GM and n-3/n-6 PUFA, which may be underlying at least in part, the pathogenesis of NAFLD. In this review, we will discuss: (1) How GM is linked to NAFLD by interacting with various nutrients; (2) How imbalanced dietary n-3/n-6 PUFA is linked to NAFLD; (3) How n-3/n-6 PUFA may affect the GM balance, leading to altered nutrients release to the liver; and (4) How GM may modify ingested n-3/n-6 PUFA and alter their absorption, bioavailability, and biotransformation.
非酒精性脂肪性肝病(NAFLD)是最常见的慢性肝病,其特征为肝脂肪变性、炎症和纤维化的谱。NAFLD 的病因仍不完全清楚。许多研究表明,肠道微生物群(GM)参与了 NAFLD 的发生,因为它特别介导了营养摄入与肠道-肝脏功能之间的相互作用。同时,ω-3 和 ω-6 多不饱和脂肪酸(n-3/n-6PUFA)作为必需脂肪酸与 NAFLD 有关。过去几十年的越来越多的研究表明,GM 和 n-3/n-6PUFA 之间存在相互作用,这可能至少部分是 NAFLD 发病机制的基础。在这篇综述中,我们将讨论:(1)GM 如何通过与各种营养素相互作用与 NAFLD 相关;(2)膳食 n-3/n-6PUFA 失衡如何与 NAFLD 相关;(3)n-3/n-6PUFA 如何影响 GM 平衡,导致肝脏释放改变的营养素;以及(4)GM 如何修饰摄入的 n-3/n-6PUFA 并改变它们的吸收、生物利用度和生物转化。